Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine related diseases and disorders. Its products in clinical development comprise Elagolix, a Phase II product for Endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for Cardiovascular related diseases; CRF1 Antagonist, a Phase I product for treating Mood Disorders and Irritable Bowel Syndrome; and Elagolix, a Phase I product for treating Benign Prostatic Hyperplasia and Uterine Fibroids. The company's research programs include Vesicular Monoamine Transporter 2 Inhibitor for movement disorders and schizophrenia; Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. It has strategic alliances with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; and Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize indiplon in Japan. Neurocrine Biosciences, Inc. was founded in 1992 and is based in San Diego, California.The staff at Neurocrine Biosciences come from unusually diverse demographic backgrounds. The company is 41.4% female and 45.0% ethnic minorities. Even though it has great demographic diversity, Neurocrine Biosciences notably lacks in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 82.0%. Despite having coworkers who agree with each other about politics, employees at Neurocrine Biosciences tend to have relatively short tenures. Staff members usually stay with the company for 2.9 years.The average employee at Neurocrine Biosciences makes $78,232 per year. Pay at Neurocrine Biosciences is significantly lower than some of its highest paying competitors, like Exelixis, Gilead Sciences, and Halozyme, which pay $108,978, $99,828, and $93,996, respectively.Neurocrine Biosciences is a medium health care company with 400 employees and an annual revenue of $2.4B that is headquartered in San Diego, CA.
Neurocrine Biosciences's mission statement
To relieve patient suffering begins with our leadership team. They lead our effort to relentlessly pursue medicines to ease the burden of debilitating diseases and disorders.
In demand companies are hiring! Let Zippia apply for you!
-
Neurocrine Biosciences employee reviews
Be the first to review!
Do you work at Neurocrine Biosciences?
Help job seekers learn about working at Neurocrine Biosciences
The founders of Neurocrine Biosciences are Kevin Charles Gorman, Wylie W Vale, Larry Bock and Errol de Souza.
The key people at Neurocrine Biosciences are Kevin Charles Gorman, Wylie W Vale and Larry Bock.
Key people
Kevin Charles Gorman
Wylie W Vale
Larry Bock
Errol de Souza
Neurocrine Biosciences rankings
Neurocrine Biosciences is ranked #75 on the Best Health Care companies to work for in California list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Rate Neurocrine Biosciences' promotion and raise policies.
Neurocrine Biosciences diversity
8.9
Diversity score
We calculated Neurocrine Biosciences’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Neurocrine Biosciences’s workforce.
Neurocrine Biosciences diversity summary. Zippia estimates Neurocrine Biosciences's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Neurocrine Biosciences's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Neurocrine Biosciences's workforce.
Neurocrine Biosciences has 400 employees.
41% of Neurocrine Biosciences employees are women, while 59% are men.
The most common ethnicity at Neurocrine Biosciences is White (55%).
22% of Neurocrine Biosciences employees are Hispanic or Latino.
9% of Neurocrine Biosciences employees are Asian.
The average employee at Neurocrine Biosciences makes $78,232 per year.
Neurocrine Biosciences employees are most likely to be members of the democratic party.
Employees at Neurocrine Biosciences stay with the company for 2.9 years on average.
Do you work at Neurocrine Biosciences?
Did Neurocrine Biosciences' compensation package meet your expectations?
Neurocrine Biosciences financial performance
9.6
Performance score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Neurocrine Biosciences currently has 1.5B in revenue. Neurocrine Biosciences's most recent quarter produced 498.8m (q3'2023).
Neurocrine Biosciences annual revenue
$2B
$2B
$1B
$942M
$471M
$0
2019
2020
2021
2022
2023
2024
Highest paying Neurocrine Biosciences competitors
Compare Neurocrine Biosciences salaries to competitors, including Exelixis, Gilead Sciences, and Halozyme. Employees at Exelixis earn the highest average yearly salary of $108,978. The salaries at Gilead Sciences average $99,828 per year, and the salaries at Halozyme come in at $93,996 per year.
Rank
Company
Average salary
Jobs
1
$108,978
0
2
$99,828
0
3
$93,996
0
4
$93,349
0
5
$90,328
0
6
$85,589
0
7
$85,008
0
8
$84,495
0
9
$70,157
0
10
$64,435
0
Show more
Are you an executive, HR leader, or brand manager at Neurocrine Biosciences?
Claiming and updating your company profile on Zippia is free and easy.
Neurocrine Biosciences FAQs
When was Neurocrine Biosciences founded?
How many employees does Neurocrine Biosciences have?
Zippia gives an in-depth look into the details of Neurocrine Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Neurocrine Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Neurocrine Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Neurocrine Biosciences. The data presented on this page does not represent the view of Neurocrine Biosciences and its employees or that of Zippia.
Neurocrine Biosciences may also be known as or be related to NEUROCRINE BIOSCIENCES. INC, Neurocrine Biosciences, Neurocrine Biosciences Inc, Neurocrine Biosciences Inc. and Neurocrine Biosciences, Inc.